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management. According to protocol, patients were dialyzed when
they remained oliguric despite 1,000 mg of furosemide. In a setting
where dialysis is possible at any time, the approach to oliguria
might be the application of volume rather than furosemide!
No study has so far been done in patients with such an advanced
degree of renal failure (i.e., with a mean creatinine clearance of
about 13  4 ml/min), and the observed poor outcome of the
patients in the control group might well be related to the advanced
renal failure before the procedure. However, polymorbid patients
with a glomerular filtration rate slightly above 10 ml/min might
profit from the initiation of a chronic renal replacement therapy
even without the administration or radiocontrast media.
Given all the information available today, the study by Lee et al.
(1) does not provide enough evidence to prophylactically dialyze all
patients with advanced renal failure; nevertheless, it certainly
reopens the discussion about this subject!
*Dominik E. Uehlinger, MD
*Universität Bern
Klinik und Poliklinik für Nephrologie und Hypertonie
Freiburgstrasse 15
3010 Bern-Inselspital
Switzerland
E-mail: uehlinger@mph.unibe.ch
doi:10.1016/j.jacc.2007.10.051
REFERENCES
1 . Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography
in advanced renal failure patients by prophylactic hemodialysis. A random-
ized controlled trial. J Am Coll Cardiol 2007;50:1015–20.
2. Cruz DN, Perazella MA, Bellomo R, et al. Extracorporeal blood
purification therapies for prevention of radiocontrast-induced nephrop-
athy: a systematic review. Am J Kidney Dis 2006;48:361–71.
3. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after
media in patients with renal insufficiency is potentially harmful. Am J
Med 2001;111:692– 8.
Reply
Many previous studies have shown renal failure is the main risk factor
predicting development of contrast nephropathy. Renal failure im-
pairs excretion of contrast medium, prolongs exposure to contrast
medium, and enhances its damage. According to the pharmacokinetic
characteristics of contrast medium, it can be efficiently removed from
plasma by hemodialysis, even better than by a normal kidney (1).
Theoretically, reduction of exposure of contrast medium by hemodi-
alysis should prevent contrast nephropathy. Although detailed com-
parison between our experiment and previous studies had not been
mentioned in our report (2), I would like to re-emphasize the key
factor resulting in a beneficial impact of preventive dialysis in contrast
nephropathy is selection of high-risk patients. Most previous studies
with a negative result either included a small number of patients or
were not properly randomized (3,4).
It is generally accepted that renal replacement therapy should be
started when glomerular filtration rate is 15 ml/min with uremic
symptoms or evidence of malnutrition. However, until now, no strict
randomized controlled trial has proven that early initiation of dialysis
accounts for a better survival. Despite the availability of clinical
guidelines for the timing of dialysis initiation, most patients started
the treatment at very low levels of glomerular filtration rate. There-
fore, in addition to an uneventful post-catheterization course, shorter
duration of hospitalization, and lower costs, preventive hemodialysis
can prevent early entrance of an unexpected dialysis-dependent
condition. According to our preliminary results of post-hospitalization
follow-up, the benefit can be maintained for as long as 1 year after
contrast exposure, showing a more than 2-fold 1-year cumulative
dialysis-free survival (85% vs. 40%, p  0.001). Furthermore, patients
with moderate renal failure might benefit from the strategy as well as
those with advanced renal failure. In this patient population, it is more
difficult to appreciate its impact in short-term investigation. To justify
use of preventive hemodialysis in these patients, future investigation
should look into the impact of the strategy applied in diabetes patients
with moderate renal failure and focus on the incidence of plasma
creatinine level doubling after contrast medium exposure.
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